You are here

  • Home
  • Archive
  • Volume 90, Issue 6
  • Improvement of cardiac hypertrophy and ventricular function in a man with Fabry disease by treatment with recombinant α-galactosidase A

Article Text

Article menu
Download PDFPDF
Miscellanea
Improvement of cardiac hypertrophy and ventricular function in a man with Fabry disease by treatment with recombinant α-galactosidase A
  1. K Komamura,
  2. M Higashi,
  3. N Yamada
  1. kkoma@hsp.ncvc.go.jp

https://doi.org/10.1136/hrt.2003.023903

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    A 35 year old man was diagnosed as having Fabry disease because of extremely low activity of α-galactosidase A and a point mutation of its gene. He had been suffering from acroparesthesias, angiokeratoma, corneal opacity, and hypohidrosis. Since his neuropathic pain was resistant to conventional treatment, he agreed with written informed …

    View Full Text